SEC Company Response from CBD Life Sciences Inc. (CBDL) (CIK 0001776073) (CBDL) — Mar 5, 2020

CBD Life Sciences Inc. (CBDL) (CIK 0001776073)
Date: March 5, 2020 · CIK: 0001776073 · Accession: 0001683168-20-000692

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

March 5, 2020

Author

/s/ Lisa Nelson

Form

CORRESP

Company

CBD Life Sciences Inc. (CBDL) (CIK 0001776073)

Letter

Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Re: CBD Life Sciences Inc. CIK: 0001776073

Dear Sir/Madam:

Kindly be advised that CBD Life Sciences Inc. (the "Company") requests that its Regulation A offering be qualified on Thursday, March 5, 2020 at 12 Noon.

The State of New York has registered us.

If you would like any further information or have any questions, please do not hesitate to contact me.

Sincerely,
/s/ Lisa Nelson

Show Raw Text

CORRESP
1
filename1.htm

Lisa Nelson

CBD Life Sciences Inc.

10855 N. 116th St

Suite 115

Scottsdale, AZ 85259

March 5, 2020

Securities and Exchange Commission

100 F Street NE

Washington, DC 20549

    Re:
    CBD Life Sciences Inc.

CIK: 0001776073

Dear Sir/Madam:

Kindly be advised that CBD Life Sciences Inc. (the "Company")
requests that its Regulation A offering be qualified on Thursday, March 5, 2020 at 12 Noon.

The State of New York has registered us.

If you would like any further information or have any questions,
please do not hesitate to contact me.

Sincerely,

/s/ Lisa Nelson

Lisa Nelson

Chief Executive Officer

SecProbe.io